Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.47
Current Ratio1.43
Quick Ratio1.43
Price-To-Earnings
Trailing P/E Ratio27.72
Forward P/E Ratio22.89
P/E Growth1.62
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.83
Cash Flow$15.3123 per share
Price / Cash21.20
Book Value$68.89 per share
Price / Book4.71
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins2.48%
Return on Equity17.43%
Return on Assets5.64%
Miscellaneous
Employees45,900
Outstanding Shares137,760,000
Market Cap$44.78 billion
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana announced a quarterly dividend on Thursday, August 16th. Investors of record on Friday, September 28th will be given a dividend of $0.50 per share on Friday, October 26th. This represents a $2.00 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, September 27th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana announced that its Board of Directors has authorized a share buyback program on Friday, December 15th 2017, which allows the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company's board believes its stock is undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) issued its quarterly earnings data on Wednesday, August, 1st. The insurance provider reported $3.96 earnings per share for the quarter, topping the consensus estimate of $3.79 by $0.17. The insurance provider had revenue of $14.26 billion for the quarter, compared to the consensus estimate of $14.16 billion. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same period in the prior year, the firm earned $3.49 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana issued an update on its FY18 earnings guidance on Wednesday, August, 1st. The company provided earnings per share (EPS) guidance of $14.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.98.
What price target have analysts set for HUM?
17 brokerages have issued 12 month price objectives for Humana's stock. Their predictions range from $246.00 to $375.00. On average, they expect Humana's stock price to reach $317.5294 in the next year. This suggests that the stock has a possible downside of 2.2%. View Analyst Price Targets for Humana.
What is the consensus analysts' recommendation for Humana?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.
What are Wall Street analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- 1. According to Zacks Investment Research, "Shares of Humana have outperformed its industry’s growth year to date. Moreover, the company has witnessed its 2018 and 2019 earnings estimates move upward over the last seven days. The insurer is well-poised for growth on its strong Medicare business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholder value. Humana’s sound balance sheet and a disciplined capital management remain its major tailwinds. Acquisitions and dispositions made by the company have also led to business growth over the last few quarters. Following the solid second-quarter results and the buyouts of Curo Healthcare and Kindred, the company provided a bullish EPS guidance for 2018. However, its rising level of expenses persistently weighs on the bottom line." (8/8/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Has Humana been receiving favorable news coverage?
News articles about HUM stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Humana earned a coverage optimism score of 0.14 on Accern's scale. They also gave headlines about the insurance provider an impact score of 45.47 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Humana.
Who are Humana's major shareholders?
Humana's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (8.87%), BlackRock Inc. (8.83%), Janus Henderson Group PLC (2.40%), Renaissance Technologies LLC (2.02%), Bank of America Corp DE (1.62%) and Newport Trust Co (1.34%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which major investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Millennium Management LLC, Bank of New York Mellon Corp, Janus Henderson Group PLC, Wells Fargo & Company MN, Jennison Associates LLC, WBI Investments Inc. and Canada Pension Plan Investment Board. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which major investors are buying Humana stock?
HUM stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Glenmede Trust Co. NA, Unigestion Holding SA, Bank of Montreal Can, Point72 Asset Management L.P., California Public Employees Retirement System, Great West Life Assurance Co. Can and Acadian Asset Management LLC. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $324.62.
How big of a company is Humana?
Humana has a market capitalization of $44.78 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (NYSE HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
